\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\:\\ hr\\=108\\,\\ rr\\=20\\ \\ o2\\ sat\\=94\\%\\ on\\ 2l\\ nc\\.\ \(0\)\
\-\ pe\\:\\ chest\\-\\ clear\\ to\\ auscultation\ \(0\)\
\-\ treatment\\:\\ anticoagulation\ \(0\)\
\-\ follow\\-up\\:\\ \\ some\\ advocate\\ a\\ 3\\-4\\ month\\ post\\-treatment\\ v\\/q\\ scan\\ to\\ monitor\\ treatment\\ and\\ basically\\ to\\ re\\-establish\\ a\\ baseline\\ \\(in\\ case\\ of\\ recurrent\\ pe\\)\\.\ \(0\)\
\-\ cxr\\ \\(pa\\/lat\\)\\:\\ \\ unremarkable\ \(0\)\
\-\ ventilation\\/perfusion\\ scintigraphy\\:\ \(0\)\
\-\ ventilation\\:\\ normal\\ \\(\\*homogeneous\\ distribution\\ on\\ wash\\-in\\ phase\\ and\\ equilibrium\\ phase\\ with\\ full\\ lung\\ outline\\ \\*progressive\\,\\ uniform\\ decrease\\ in\\ activity\\ with\\ no\\ activity\\ seen\\ on\\ last\\ wash\\-out\\ image\\)\\ \ \(0\)\
\-\ \\	\ \(2191\)\
\-\ perfusion\\:\\ \\ abnormal\\ \\(\\*large\\ segmental\\ mismatched\\ perfusion\\ defects\\ in\\ rll\\ basal\\ segments\\ and\\ rml\\ lateral\\ segment\\)\ \(0\)\
\-\ \\*high\\ probability\\ v\\/q\\ scan\\:\\ \\(2\\ or\\ more\\ mismatched\\ large\\ perfusion\\ defects\\)\\.\ \(0\)\
\-\ pulmonary\\ embolism\ \(77\)\
\-\ differential\\ diagnosis\\ \\(v\\/q\\ mismatch\\)\ \(0\)\
\-\ \\*\\*1\\)acute\\ pulmonary\\ embolism\ \(0\)\
\-\ 2\\)chronic\\ pulmonary\\ embolism\\ \\(common\\ cause\\ of\\ false\\+\\,\\ patient\\ had\\ no\\ prior\\ history\\)\ \(0\)\
\-\ 3\\)other\\ embolic\\ causes\ \(0\)\
\-\ \\ \\ \\ \\-septic\\ emboli\\(no\\ signs\\ of\\ infection\\)\ \(1\)\
\-\ \\ \\ \\ \\-fat\\ embolism\\(unlikely\\,\\ seen\\ with\\ long\\ bone\\ fracture\\,\\ no\\ cns\\ sx\\/rash\\/ards\\ picture\\)\ \(0\)\
\-\ 28\\ y\\/o\\ female\\ s\\/p\\ left\\ total\\ hip\\ replacement\\ with\\ tachycardia\\,\\ sob\\.\ \(0\)\
\-\ given\\ the\\ risk\\ factors\\ and\\ clinical\\ picture\\ in\\ this\\ case\\,\\ the\\ patient\\ had\\ a\\ high\\ clinical\\ probability\\ for\\ pe\\ \\(scoring\\ system\\ used\\ in\\ article\\ referenced\\ below\\)\\.\ \(0\)\
\-\ high\\ clinical\\ probability\\ and\\ high\\ probability\\ v\\/q\\ scan\\ together\\ provide\\ high\\ positive\\ predictive\\ value\\ \\(95\\+\\%\\)\\ for\\ pe\\.\\ \\ therefore\\,\\ diagnosis\\ can\\ be\\ confirmed\\ without\\ further\\ work\\-up\\ and\\ the\\ patient\\ can\\ be\\ confidently\\ treated\\ \\(anticoagulation\\)\\.\ \(0\)\
\-\ likewise\\,\\ low\\ clinical\\ probability\\ and\\ normal\\ v\\/q\\ scan\\ have\\ equal\\ confidence\\ in\\ excluding\\ pe\\.\\ \\ \ \(0\)\
\-\ the\\ difficulty\\ is\\ with\\ low\\-probability\\ and\\ indeterminate\\ v\\/q\\ probabilities\\ \\(with\\ intermediate\\ or\\ high\\ clinical\\ probability\\)\\.\\ \\ these\\ patient\\'s\\ need\\ further\\ evaluation\\ \\(ct\\ angio\\-\\-often\\ performed\\ in\\ leiu\\ of\\ v\\/q\\ or\\ pulmonary\\ angiography\\-\\-role\\ is\\ becoming\\ less\\ clear\\)\\ since\\ pe\\ has\\ not\\ been\\ confidently\\ confirmed\\ or\\ excluded\\.\\ \\ \ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ fedulla\\ pf\\,\\ tapson\\ vf\\,\\ the\\ evaluation\\ of\\ suspected\\ pulmonary\\ embolism\\.\\ nejm\\;349\\:1247\\-1256\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ probability\\:\\ 0\\.4349183064077259\ \(0\)\
\-\ pe\\:\\ 0\\.2538505046312996\ \(0\)\
\-\ embolism\\:\\ 0\\.23197387732143876\ \(0\)\
\-\ perfusion\\:\\ 0\\.20531835125127562\ \(0\)\
\-\ high\\:\\ 0\\.1745154331892058\ \(0\)\
\-\ clinical\\:\\ 0\\.1621692884774534\ \(0\)\
\-\ pulmonary\\:\\ 0\\.15597505496965938\ \(0\)\
\-\ confidently\\:\\ 0\\.15125042576536116\ \(0\)\
\-\ mismatched\\:\\ 0\\.14724650290065144\ \(0\)\
\-\ scan\\:\\ 0\\.12145203554838507\ \(0\)\
\-\ picture\\:\\ 0\\.10742675673761055\ \(0\)\
\-\ in\\:\\ 0\\.10185029565673398\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.0949894363288073\ \(0\)\
\-\ defects\\:\\ 0\\.08824185128406314\ \(0\)\
\-\ phase\\:\\ 0\\.08758451549011584\ \(0\)\
\-\ and\\:\\ 0\\.08460153664321164\ \(0\)\
\-\ probabilities\\:\\ 0\\.08184387308708221\ \(0\)\
\-\ leiu\\:\\ 0\\.08184387308708221\ \(0\)\
\-\ fedulla\\:\\ 0\\.08184387308708221\ \(0\)\
\-\ tapson\\:\\ 0\\.08184387308708221\ \(0\)\
\-\ equilibrium\\:\\ 0\\.0782061900627803\ \(0\)\
\-\ scoring\\:\\ 0\\.0782061900627803\ \(0\)\
\-\ pf\\:\\ 0\\.0782061900627803\ \(0\)\
\-\ basically\\:\\ 0\\.07562521288268058\ \(0\)\
\-\ mismatch\\:\\ 0\\.07562521288268058\ \(0\)\
\-\ referenced\\:\\ 0\\.07562521288268058\ \(0\)\
\-\ confidence\\:\\ 0\\.07562521288268058\ \(0\)\
\-\ confirmed\\:\\ 0\\.0754728530307169\ \(0\)\
\-\ activity\\:\\ 0\\.07514719508131257\ \(0\)\
\-\ clear\\:\\ 0\\.07420424991228146\ \(0\)\
\-\ advocate\\:\\ 0\\.07362325145032572\ \(0\)\
\-\ vf\\:\\ 0\\.07362325145032572\ \(0\)\
\-\ treatment\\:\\ 0\\.07313559531776137\ \(0\)\
\-\ or\\:\\ 0\\.07121488485907958\ \(0\)\
\-\ 2l\\:\\ 0\\.06940655267827896\ \(0\)\
\-\ excluding\\:\\ 0\\.06940655267827896\ \(0\)\
\-\ angio\\:\\ 0\\.06940655267827896\ \(0\)\
\-\ likewise\\:\\ 0\\.06834984683407676\ \(0\)\
\-\ further\\:\\ 0\\.06666545464185432\ \(0\)\
\-\ patient\\:\\ 0\\.06658181246812228\ \(0\)\
\-\ no\\:\\ 0\\.06656928881734034\ \(0\)\
\-\ outline\\:\\ 0\\.06654950355481537\ \(0\)\
\-\ rml\\:\\ 0\\.06505075607749265\ \(0\)\
\-\ predictive\\:\\ 0\\.06505075607749265\ \(0\)\
\-\ nejm\\:\\ 0\\.06438588675365156\ \(0\)\
\-\ evaluation\\:\\ 0\\.06242175189971436\ \(0\)\
\-\ becoming\\:\\ 0\\.06213118662967513\ \(0\)\
\-\ rll\\:\\ 0\\.06164611551244945\ \(0\)\
\-\ indeterminate\\:\\ 0\\.06164611551244945\ \(0\)\
\-\ nc\\:\\ 0\\.06033084335041374\ \(0\)\
\-\ with\\:\\ 0\\.060127099182672235\ \(0\)\
\-\ low\\:\\ 0\\.05873178804045015\ \(0\)\
\-\ together\\:\\ 0\\.05785240020334458\ \(0\)\
\-\ embolic\\:\\ 0\\.05519441284878911\ \(0\)\
\-\ article\\:\\ 0\\.05431843660287074\ \(0\)\
\-\ baseline\\:\\ 0\\.05411218314601211\ \(0\)\
\-\ role\\:\\ 0\\.05371337836880528\ \(0\)\
\-\ can\\:\\ 0\\.05371260178623535\ \(0\)\
\-\ uniform\\:\\ 0\\.05352043264774317\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.05314656062462252\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05306004767398877\ \(0\)\
\-\ sob\\:\\ 0\\.05296530940476595\ \(0\)\
\-\ o2\\:\\ 0\\.0527876475549264\ \(0\)\
\-\ monitor\\:\\ 0\\.052274843400971584\ \(0\)\
\-\ tachycardia\\:\\ 0\\.052274843400971584\ \(0\)\
\-\ intermediate\\:\\ 0\\.052274843400971584\ \(0\)\
\-\ value\\:\\ 0\\.052110221713657236\ \(0\)\
\-\ segments\\:\\ 0\\.05194856634484829\ \(0\)\
\-\ provide\\:\\ 0\\.051789772283745907\ \(0\)\
\-\ case\\:\\ 0\\.05142198194197228\ \(0\)\
\-\ large\\:\\ 0\\.05128487899813288\ \(0\)\
\-\ the\\:\\ 0\\.05105877161087953\ \(0\)\
\-\ had\\:\\ 0\\.050996967745026135\ \(0\)\
\-\ excluded\\:\\ 0\\.050339585846433194\ \(0\)\
\-\ emboli\\:\\ 0\\.050206670374826685\ \(0\)\
\-\ of\\:\\ 0\\.05007599559012755\ \(0\)\
\-\ reference\\:\\ 0\\.05007569534450336\ \(0\)\
\-\ equal\\:\\ 0\\.04897575264438748\ \(0\)\
\-\ segmental\\:\\ 0\\.04852707764295156\ \(0\)\
\-\ seen\\:\\ 0\\.04818785179818745\ \(0\)\
\-\ auscultation\\:\\ 0\\.04789352294161048\ \(0\)\
\-\ cns\\:\\ 0\\.047792147510019874\ \(0\)\
\-\ angiography\\:\\ 0\\.047301772443341536\ \(0\)\
\-\ need\\:\\ 0\\.047112889040772155\ \(0\)\
\-\ on\\:\\ 0\\.046369398906880556\ \(0\)\
\-\ replacement\\:\\ 0\\.04597349477493865\ \(0\)\
\-\ unlikely\\:\\ 0\\.04533806962008556\ \(0\)\
\-\ homogeneous\\:\\ 0\\.04518600445019928\ \(0\)\
\-\ therefore\\:\\ 0\\.04511092760841728\ \(0\)\
\-\ decrease\\:\\ 0\\.04398801017042505\ \(0\)\
\-\ basal\\:\\ 0\\.04379225774505792\ \(0\)\
\-\ distribution\\:\\ 0\\.04341311836218645\ \(0\)\
\-\ factors\\:\\ 0\\.04329021739591897\ \(0\)\
\-\ difficulty\\:\\ 0\\.043049353795690824\ \(0\)\
\-\ 28\\:\\ 0\\.04247405223977623\ \(0\)\
\-\ segment\\:\\ 0\\.0422538784849537\ \(0\)\
\-\ below\\:\\ 0\\.04214578524680596\ \(0\)\
\-\ total\\:\\ 0\\.04193342905504236\ \(0\)\
\-\ suspected\\:\\ 0\\.04193342905504236\ \(0\)\
\-\ normal\\:\\ 0\\.041790813824247784\ \(0\)\
\-\ last\\:\\ 0\\.04162403183501396\ \(0\)\
\-\ be\\:\\ 0\\.04152128551147229\ \(0\)\
\-\ recurrent\\:\\ 0\\.04103551727194255\ \(0\)\
\-\ cxr\\:\\ 0\\.040941078186892244\ \(0\)\
\-\ full\\:\\ 0\\.04000522189791032\ \(0\)\
\-\ hip\\:\\ 0\\.03931318866025087\ \(0\)\
\-\ progressive\\:\\ 0\\.0391964195901397\ \(0\)\
\-\ vs\\:\\ 0\\.03904305465491425\ \(0\)\
\-\ system\\:\\ 0\\.03904305465491425\ \(0\)\
\-\ causes\\:\\ 0\\.03867073441424801\ \(0\)\
\-\ to\\:\\ 0\\.03838278083907168\ \(0\)\
\-\ used\\:\\ 0\\.03831325165627081\ \(0\)\
\-\ since\\:\\ 0\\.03707155719151734\ \(0\)\
\-\ risk\\:\\ 0\\.036567233641500434\ \(0\)\
\-\ signs\\:\\ 0\\.035767388533668544\ \(0\)\
\-\ given\\:\\ 0\\.03520487992993264\ \(0\)\
\-\ cause\\:\\ 0\\.03486445203453828\ \(0\)\
\-\ less\\:\\ 0\\.03481685706754092\ \(0\)\
\-\ unremarkable\\:\\ 0\\.03430932879156106\ \(0\)\
\-\ long\\:\\ 0\\.033935914516354374\ \(0\)\
\-\ positive\\:\\ 0\\.03372330669419198\ \(0\)\
\-\ often\\:\\ 0\\.03339327848601427\ \(0\)\
\-\ differential\\:\\ 0\\.03325262294735886\ \(0\)\
\-\ image\\:\\ 0\\.032729855849306495\ \(0\)\
\-\ some\\:\\ 0\\.0322003486321368\ \(0\)\
\-\ treated\\:\\ 0\\.031869640047033375\ \(0\)\
\-\ month\\:\\ 0\\.03113183023818614\ \(0\)\
\-\ lung\\:\\ 0\\.03113183023818614\ \(0\)\
\-\ for\\:\\ 0\\.031022980545220853\ \(0\)\
\-\ infection\\:\\ 0\\.030914137021743917\ \(0\)\
\-\ abnormal\\:\\ 0\\.030746722609041145\ \(0\)\
\-\ chronic\\:\\ 0\\.030377467601326202\ \(0\)\
\-\ performed\\:\\ 0\\.030276742547077427\ \(0\)\
\-\ been\\:\\ 0\\.02981655807615043\ \(0\)\
\-\ fracture\\:\\ 0\\.029085905531534294\ \(0\)\
\-\ common\\:\\ 0\\.02902347222294838\ \(0\)\
\-\ these\\:\\ 0\\.028899894095016827\ \(0\)\
\-\ prior\\:\\ 0\\.028633869396172292\ \(0\)\
\-\ more\\:\\ 0\\.028101890139889264\ \(0\)\
\-\ is\\:\\ 0\\.02803058105705803\ \(0\)\
\-\ bone\\:\\ 0\\.027924008124643063\ \(0\)\
\-\ acute\\:\\ 0\\.02768504016517696\ \(0\)\
\-\ without\\:\\ 0\\.02699417717781042\ \(0\)\
\-\ other\\:\\ 0\\.02657726791793121\ \(0\)\
\-\ have\\:\\ 0\\.025565940056752185\ \(0\)\
\-\ lateral\\:\\ 0\\.025398241151010185\ \(0\)\
\-\ female\\:\\ 0\\.024695476817342285\ \(0\)\
\-\ has\\:\\ 0\\.023376364881981162\ \(0\)\
\-\ not\\:\\ 0\\.020203637203612516\ \(0\)\
\-\ history\\:\\ 0\\.019552746013325403\ \(0\)\
\-\ ct\\:\\ 0\\.0194837331327326\ \(0\)\
\-\ this\\:\\ 0\\.017585491124205793\ \(0\)\
\-\ left\\:\\ 0\\.017457742066090767\ \(0\)\
